A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01)
Patent
CA 2587697
The invention relates to compositions and methods for modulating the expression of Bcr-Abl, and more particularly to the down-regulation of Bcr-Abl mRNA and Bcr-Abl protein levels by oligonucleotides via RNA interference, e.g., chemically modified oligonucleotides.
L'invention concerne des compositions et des procédés pour moduler l'expression de Bcr-Abl, et plus particulièrement la diminution d'ARNm Bcr-Abl et de la protéine Bcr-Abl dans des oligonucléotides par interférence ARN, à savoir, des oligonucléotides chimiquement modifiées.
Hadwiger Philipp
Van Der Kuip Heiko
Vornlocher Hans-Peter
Alnylam Pharmaceuticals Inc.
Smart & Biggar
LandOfFree
Rnai modulation of the bcr-abl fusion gene and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rnai modulation of the bcr-abl fusion gene and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rnai modulation of the bcr-abl fusion gene and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1445397